9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
AstraZeneca
EMD Serono
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Nimbus Therapeutics
Pfizer
EMD Serono
Asana BioSciences
Seagen Inc.
Emory University